Redefining personalized medicine in the postgenomic era: developing bladder cancer therapeutics with proteomics.
Blanchet
Kevin D
KD
D014408:Biomarkers, Tumor / Q000652:urine; D015870:Gene Expression; D006801:Humans; D057285:Precision Medicine; D040901:Proteomics; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000628:therapy*
D014408:Biomarkers, Tumor